CLINICAL_TRIALS
trial_result
· 2024-05-20
Clinical Trial Update: Shigella CVD 30000: Study of Responses to Vaccination With Shigella Vaccine [Phase 2]
Summary
A Phase 2 clinical trial evaluating responses to vaccination with Shigella vaccine CVD 30000 has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Maryland, Baltimore | Conditions: Shigella | Phase 2 | Status: COMPLETED | Results posted: 2024-05-20